PMED — Peptonic Medical AB Balance Sheet
0.000.00%
- SEK10.37m
- SEK14.54m
- SEK14.79m
Annual balance sheet for Peptonic Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | SAS | SAS | SAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 10.2 | 3.57 | 15.1 | 3.74 | 0.195 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.69 | — | 6.37 | 2.64 | 7.02 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 27.1 | 31.4 | 40.4 | 12.5 | 13.6 |
| Net Property, Plant And Equipment | 4.2 | 4.3 | 3.78 | 0.402 | 0.311 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 83.5 | 85.8 | 107 | 70.5 | 65.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 31.5 | 35.1 | 31.4 | 21.9 | 27.7 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 31.5 | 38.7 | 31.4 | 21.9 | 27.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 52 | 47.1 | 75.3 | 48.6 | 38.2 |
| Total Liabilities & Shareholders' Equity | 83.5 | 85.8 | 107 | 70.5 | 65.9 |
| Total Common Shares Outstanding |